Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perifosine in advanced renal cell carcinoma
NCT00448721Phase 2Completed
- Sponsor
- COSCIENS Biopharma Inc.
- Start
- Mar 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of perifosine in renal cell carcinoma (RCC), sponsored by COSCIENS Biopharma Inc. Primary endpoint: Progression Free Survival. Started Mar 2007; status: completed.
02
Drugs
perifosine
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT00448721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00448721.